These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10733746)

  • 1. Frequency of CCR5 delta-32 mutation in human immunodeficiency virus (HIV)-seropositive and HIV-exposed seronegative individuals and in general population of Medellin, Colombia.
    Díaz FJ; Vega JA; Patiño PJ; Bedoya G; Nagles J; Villegas C; Vesga R; Rugeles MT
    Mem Inst Oswaldo Cruz; 2000; 95(2):237-42. PubMed ID: 10733746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV).
    Rugeles MT; Solano F; Díaz FJ; Bedoya VI; Patiño PJ
    J Clin Virol; 2002 Jan; 23(3):161-9. PubMed ID: 11595595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first report of CCR5 delta 32 mutant in Thai injecting drug users.
    Ruchusatsawat N; Vongsheree S; Thaisri H; Phutiprawan T
    Asian Pac J Allergy Immunol; 2000 Jun; 18(2):93-8. PubMed ID: 10928621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.
    Trecarichi EM; Tumbarello M; de Gaetano Donati K; Tamburrini E; Cauda R; Brahe C; Tiziano FD
    AIDS Res Ther; 2006 Sep; 3():22. PubMed ID: 16999868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.
    Li C; Yan YP; Shieh B; Lee CM; Lin RY; Chen YM
    J Formos Med Assoc; 1997 Dec; 96(12):979-84. PubMed ID: 9444918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.
    Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1149-56. PubMed ID: 19886839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 chemokine receptor genotype frequencies among Puerto Rican HIV-1-seropositive individuals.
    Gonzalez S; Tirado G; Revuelta G; Yamamura Y; Lu Y; Nerurkar VR; Yanagihara R
    Bol Asoc Med P R; 1998; 90(1-3):12-5. PubMed ID: 9734151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
    Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
    J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the CCR5 delta 32 allele in resistance to HIV-1 infection in west Africa.
    Kokkotou E; Philippon V; Guèye-Ndiaye A; Mboup S; Wang WK; Essex M; Kanki P
    J Hum Virol; 1998; 1(7):469-74. PubMed ID: 10195268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of mutant CCR5 allele in Slovenian HIV-1-infected and non-infected individuals.
    Poljak M; Tomazic J; Seme K; Maticic M; Vidmar L
    Acta Virol; 1998 Feb; 42(1):23-6. PubMed ID: 9645239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users.
    Alvarez V; López-Larrea C; Coto E
    Hum Genet; 1998 Apr; 102(4):483-6. PubMed ID: 9600249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CCR2 and CCRS polymorphisms on HIV-1 infection in Thai females.
    Wichukchinda N; Nakayama EE; Rojanawiwat A; Pathipvanich P; Auwanit W; Vongsheree S; Ariyoshi K; Sawanpanyalert P; Shioda T
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):293-7. PubMed ID: 18197127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.
    Philpott S; Weiser B; Tarwater P; Vermund SH; Kleeberger CA; Gange SJ; Anastos K; Cohen M; Greenblatt RM; Kovacs A; Minkoff H; Young MA; Miotti P; Dupuis M; Chen CH; Burger H
    J Infect Dis; 2003 Feb; 187(4):569-75. PubMed ID: 12599073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
    Tiensiwakul P
    Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.
    Quillent C; Oberlin E; Braun J; Rousset D; Gonzalez-Canali G; Métais P; Montagnier L; Virelizier JL; Arenzana-Seisdedos F; Beretta A
    Lancet; 1998 Jan; 351(9095):14-8. PubMed ID: 9433423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of the CCR5-delta 32 chemokine receptor gene mutation in the Lebanese population.
    Karam W; Jurjus R; Khoury N; Khansa H; Assad C; Zalloua P; Jurjus A
    East Mediterr Health J; 2004; 10(4-5):671-5. PubMed ID: 16335661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.
    Zapata W; Aguilar-Jiménez W; Pineda-Trujillo N; Rojas W; Estrada H; Rugeles MT
    AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1594-603. PubMed ID: 24098976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.